2023 ICD-10-CM Diagnosis Code E30

Disorders of puberty, not elsewhere classified

2016

2017

2018

2019

2020

2021

2022

2023

Non-Billable/Non-Specific Code

E30 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
The 2023 edition of ICD-10-CM E30 became effective on October 1, 2022.
This is the American ICD-10-CM version of E30 - other international versions of ICD-10 E30 may differ.

The following code(s) above E30 contain annotation back-references

Annotation Back-References

In this context, annotation back-references refer to codes that contain:

that may be applicable to E30:

Code History

2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
2017 (effective 10/1/2016): No change
2018 (effective 10/1/2017): No change
2019 (effective 10/1/2018): No change
2020 (effective 10/1/2019): No change
2021 (effective 10/1/2020): No change
2022 (effective 10/1/2021): No change
2023 (effective 10/1/2022): No change

ICD-10-CM Codes Adjacent To E30

E28.310 Symptomatic premature menopause

E28.319 Asymptomatic premature menopause

E28.39 Other primary ovarian failure

E28.8 Other ovarian dysfunction

E28.9 Ovarian dysfunction, unspecified

E29 Testicular dysfunction

E29.0 Testicular hyperfunction

E29.1 Testicular hypofunction

E29.8 Other testicular dysfunction

E29.9 Testicular dysfunction, unspecified

E30 Disorders of puberty, not elsewhere classified

E30.0 Delayed puberty

E30.1 Precocious puberty

E30.8 Other disorders of puberty

E30.9 Disorder of puberty, unspecified

E31 Polyglandular dysfunction

E31.0 Autoimmune polyglandular failure

E31.1 Polyglandular hyperfunction

E31.2 Multiple endocrine neoplasia [MEN] syndromes

E31.20 Multiple endocrine neoplasia [MEN] syndrome, unspecified

E31.21 Multiple endocrine neoplasia [MEN] type I

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.